Seno Medical Instruments, Inc., a San Antonio, Texas-based medical imaging company, raised $34.6m of a $39m Series C equity funding.
The round was led by MedCare Investment Funds.
Led by Janet Campbell, CEO, Seno Medical Instruments develops opto-acoustic imaging tools to improve the process of diagnosing breast cancer. The company intends to use the funds for ongoing U.S. Pivotal Study of the Imagio® breast imaging device, as well as activities to obtain the CE Mark in Europe, which the company seeks to receive by the end of the first quarter of 2014.
Imagio combines an imaging technology based on light-in and sound-out called “opto-acoustics” with conventional ultrasound to provide a blood map in and around suspicious breast masses without exposing patients to potentially harmful ionizing radiation (x-rays) or injectable contrast agents.
FinSMEs
26/02/2014